Switching from Levodopa/Carbidopa Intestinal Gel to Continuous Subcutaneous Foslevodopa/Carbidopa Infusion in Advanced Parkinson's Disease: A Case Series
Switching from LCIG to CSFLI is feasible and safe, providing stable dopaminergic delivery with modest symptomatic benefits in selected aPD patients.
Authors
- Clément Desjardins (ORCID: https://orcid.org/0000-0003-1569-9590)
- Quentin Salardaine (ORCID: https://orcid.org/0000-0002-5513-9865)
- Guillaume Baille
- Nathalie Patte‐Karsenti
- Jean‐Philippe Brandel
- Hélène de Saint‐Vaulry
Institutions
- Université Paris Cité (FR)
- Fondation de Rothschild (FR)
Publication Details
- Journal
- Movement Disorders Clinical Practice
- Published
- 2025-08-25
- DOI
- https://doi.org/10.1002/mdc3.70317
- Citations
- 2
- Primary Topic
- Neurological disorders and treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.78